Angiotensin Converting Enzyme Inhibitors (ACEI) and Angiotensin Receptor Blockers (ARB), are being used by the cardiologists in initiating hypertension treatment depending on the age and gender of the patient, severity of hypertension and associated diseases. While choosing a specific antihypertensive drug or a drug combination one should consider the factors like the previous favorable or unfavorable experience of the individual patient with a given class of drugs, the effect of drugs on cardiovascular risk factors in relation to the cardiovascular risk profile of the individual patient, the presence of sub-clinical organ damage, clinical cardiovascular disease, renal disease or diabetes which may be more favorably treated by some drugs than others, the presence of other disorders that may limit the use of particular classes of antihypertensive drugs, the possibilities of interactions with drugs used for other conditions and the cost of drugs. 6 Again, it is very important to use the right antihypertensive drug for the right patient to achieve the goals of hypertension management. Therefore, the current study was carried out with an objective to evaluate the patterns of the utilization of the commonly used antihypertensive drugs.
Methods

Procedure:
During the summer 2010, a questionnaire with a cover letter was sent to 441 cardiologists working in different cities of Bangladesh. They were requested to provide their opinions on which antihypertensive they use most in initiating hypertension treatment depending on age and gender of the patient and on the severity of hypertension (mild, moderate and severe). Mild, moderate and severe hypertension was defined as the patients having a blood pressure range of 140/ 90 to 159/99, 160/100 to 179/109 and >180/110 mmHg respectively. A total 200 cardiologists gave their opinion. Among the 200 filled-in questionnaires, 4 were excluded due to ambiguity in information and data of 196 filled-in questionnaires were analyzed.
Statistical analysis:
Data were analyzed by SPSS 17 software. Antihypertensive drugs usage between male and female in mild, moderate and severe hypertension was compared and the level of significance was calculated by f-test. All statistical tests were onetailed and all analyses were considered statistically significant if p<0.05.
Results:
Antihypertensive utilization in the patients < 55 years and patients >55 years are summarized in Table # 1 and Table # 2 respectively.
Patients < 55 years
In case of < 55 years old mild hypertensive patients, the mostly used antihypertensive drugs are ACEI (26.5%) for males and CCB (24.5%) for females ( Figure # 1A and 1B) . However, the overall pattern of using antihypertensive drugs did not significantly vary between male and female patients (p = 0.93). 71.4% of respondent uses mono-therapy while 22.4% uses combinations and rest 6.1% did not answer this question. The percentages of using mono-therapy or combination and of no answer are same for both male and female patients.
In case of < 55 years old moderate hypertensive patients, the mostly used antihypertensive drugs are ACEI (18.9%) for males and CCB (20.4%) for females ( Figure # 2A and 2B) . However, the overall pattern of using antihypertensive drugs did not significantly vary between male and female patients (p = 0.90). For male patients, 60.2% of respondent uses mono-therapy while 34.7% uses In case of >55 years old severe hypertensive patients, the mostly used antihypertensive drugs are combinations of ACEI+CCB+D for males (14.3%) and combinations of CCB+BB (15.3%) for females ( Figure # 6 (A) and 6(B). However, the overall pattern of using antihypertensive drugs did not significantly vary between male and female patients (p = 0.51). For male patients, 30.6% of respondent uses monotherapy while 63.3% uses combinations and rest 6.1% did not answer this question. For female patients, 30.6% of respondent uses mono-therapy while 61.2% uses combinations and rest 8.2% did not answer this question.
Discussion:
In this survey we have found that ACEI monotherapy is the mostly used antihypertensive drug class for male patients aged < 55 years having mild to moderate hypertension. CCB mono-therapy is the mostly used antihypertensive drug class for female patients aged < 55 years having mild to moderate hypertension. CCB mono-therapy is also the mostly used antihypertensive drug class for both male and female patients aged >55 years having mild to moderate hypertension. For severe hypertensive patients aged < 55 years, the mostly used antihypertensive drugs are combinations of ACEI+CCB+D for both male and females. For severe hypertensive patients aged >55 years, the mostly used antihypertensive drugs are combinations of ACEI+CCB+D for males and combinations of CCB+BB for females. However, the overall pattern of using antihypertensive drugs did not significantly vary between male and female patients. They analyzed the prescription frequencies of the various antihypertensive drugs in individual patients. However, they did not take the criteria of severity of the hypertension and it was not limited to cardiologists. They have found that ACEI is the mostly used antihypertensive drug class for both males and females aged > 60 years (48.4% in males and 44.3% females) and BB is the mostly used antihypertensive drug class for both males and females aged 41-60 years (38% in males and 41.1% females). The main difference between this study and our survey is that we are using BB at a lesser frequency. 
Conclusion:
The pattern of using antihypertensive drugs among the cardiologists of Bangladesh in initiating hypertension treatment varies depending on age and gender of the patient and on the severity of hypertension. But, the overall pattern of using antihypertensive drugs did not significantly vary between male and female patients.
